Cubicin Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

A Phase 3 Telavancin Staph Aureus Bacteremia Trial
Condition:   BacteremiaInterventions:   Drug: Telavancin;   Drug: Vancomycin;   Drug: Daptomycin;   Drug: Synthetic penicillin;   Drug: CefazolinSponsor:   Theravance Biopharma Antibiotics, Inc.Recruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 31, 2014 Category: Research Source Type: clinical trials

A Phase 3 Telavancin Staph Aureus Bacteremia Trial
Condition:   BacteremiaInterventions:   Drug: Telavancin;   Drug: Vancomycin;   Drug: Daptomycin;   Drug: Synthetic penicillin;   Drug: CefazolinSponsor:   Theravance Biopharma Antibiotics, Inc.Recruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 31, 2014 Category: Research Source Type: clinical trials

A Phase 3 Telavancin Staph Aureus Bacteremia Trial
Condition:   BacteremiaInterventions:   Drug: Telavancin;   Drug: Vancomycin;   Drug: Daptomycin;   Drug: Synthetic penicillin;   Drug: CefazolinSponsor:   Theravance Biopharma Antibiotics, Inc.Not yet recruiting - verified November 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 31, 2014 Category: Research Source Type: clinical trials